Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 9, 2016F1000ResearchOpen Access

Open drug discovery for the Zika virus

View Full Paper
Ask AI
Bookmark
Share

Authors

SESean EkinsCollaborations Pharmaceuticals (United States)DMDaniel MietchenFIZ Karlsruhe – Leibniz Institute for Information InfrastructureMCMegan CoffeeNew York University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ekins et al. (2016) studied this question.

synapsesocial.com/papers/6ab1f2d42826756be8b37751https://doi.org/10.12688/f1000research.8013.1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Experience With the Priority Review Voucher Program for Drug Development2015 · 35 citations
  2. 2Design, Synthesis, and Biological Evaluation of Antiviral Agents Targeting Flavivirus Envelope Proteins2008 · 108 citations
  3. 3Antiviral Compounds Discovered by Virtual Screening of Small−Molecule Libraries against Dengue Virus E Protein2008 · 139 citations